The orthopedic funding announcements we’ve covered since 2016 are predominately in the spine segment. It is a massive and mature segment where organic growth can be elusive. As in funding announcements, spine has been the most frequent segment for orthopedic acquisitions since 2016.
This month’s chart segments the 239 unique funding announcements we’ve covered since 2016. These announcements span the gamut of funding from large initial public offerings to small grants. We attempted to identify the primary segment impacted by the funding announcement. Those categorized as “other” were typically for general operational purposes like commercialization and business development.
The spine segment accounted for 29% of all announcements, almost double the next most frequent category of enabling technology. However, the rate of spine funding announcements has trended downward in recent years, while enabling technology and trauma announcements are accelerating.
We tracked an average of 36 funding announcements per year in the span between 2016 and 2021. Our coverage peaked in 2021 with a total of 48 announcements. Through the first half of this year, we are on pace for a total of 40 announcements led by spine, enabling technology and trauma.
The orthopedic funding announcements we’ve covered since 2016 are predominately in the spine segment. It is a massive and mature segment where organic growth can be elusive. As in funding announcements, spine has been the most frequent segment for orthopedic acquisitions since 2016.
This month’s chart segments the 239 unique funding...
The orthopedic funding announcements we’ve covered since 2016 are predominately in the spine segment. It is a massive and mature segment where organic growth can be elusive. As in funding announcements, spine has been the most frequent segment for orthopedic acquisitions since 2016.
This month’s chart segments the 239 unique funding announcements we’ve covered since 2016. These announcements span the gamut of funding from large initial public offerings to small grants. We attempted to identify the primary segment impacted by the funding announcement. Those categorized as “other” were typically for general operational purposes like commercialization and business development.
The spine segment accounted for 29% of all announcements, almost double the next most frequent category of enabling technology. However, the rate of spine funding announcements has trended downward in recent years, while enabling technology and trauma announcements are accelerating.
We tracked an average of 36 funding announcements per year in the span between 2016 and 2021. Our coverage peaked in 2021 with a total of 48 announcements. Through the first half of this year, we are on pace for a total of 40 announcements led by spine, enabling technology and trauma.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
